Case Study: a Hungary-based pharmaceutical company achieves smoother regulatory transfer and K-DMF holding in South Korea with FREYR

A Hungary-based pharmaceutical company streamlines South Korea regulatory transfer and K-DMF holding with FREYR

A Hungary-based pharmaceutical company faced challenges with the regulatory transfer and K-DMF holding for its API in South Korea. Uncertainty around the required sequence of activities and documentation posed risks of delays and non-compliance with MFDS requirements. The company engaged FREYR for strategic regulatory guidance and documentation support.

FREYR provided a detailed assessment and a clear regulatory roadmap, recommending the optimal sequence of activities and assisting with the preparation of all necessary documentation. This approach provided the client with clarity and minimized regulatory risks. As a result, FREYR helped ensure a smoother interaction with authorities, reduced potential for rework, and optimized the client's time and resources through a structured and compliant process.